多重向的CAR-T细胞策略,以克服淋巴状和髓状恶性瘤中的免疫逃避
Jessica Peter1,2,3, Fabio Toppeta1,2,3, Alexandre Trubert1,2,3
1Chair in Cellular Immunotherapy, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
Oncology research and treatment
|March 16, 2025
概括
化学抗原受体 (CAR) -T细胞疗法对血液癌症有希望,但抗原逃逸可能导致复发. 多重定位的CAR-T策略提供了改善治疗持续性和患者治疗结果的解决方案.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法是血液恶性瘤的成功治疗方法.
- 在CAR-T疗法中单抗原向可以通过抗原逃逸和随后的复发导致瘤免疫逃避.
- 目前正在开发多重向策略,以克服抗原逃逸并提高CAR-T细胞治疗的疗效.
研究的目的:
- 审查目前CAR-T细胞治疗淋巴细胞和骨髓细胞恶性瘤的现状.
- 讨论正在进行的临床试验和多目标CAR-T方法的未来方向.
- 突出在CAR-T细胞治疗中改善患者治疗结果的策略.
主要方法:
- 关于CAR-T细胞疗法的当前文献的综述.
- 分析多目标策略,包括逻辑门式CAR和适配器CAR.
- 探索用于目标识别和治疗设计的先进技术,如NGS和CRISPR查.
主要成果:
- 卡特-T细胞疗法在耐药性和复发性血液癌症中显示出高缓解率.
- 多重准策略显示出降低免疫逃避并增加治疗持续时间的潜力.
- 先进的技术对于识别新目标和个性化CAR-T细胞治疗至关重要.
结论:
- 在CAR-T细胞疗法中,抗原逃逸仍然是一个重大挑战.
- 多重定位策略和优化的CAR设计是改善治疗成功的关键.
- 使用先进技术的个性化方法可以提高CAR-T细胞疗法的耐用性和有效性,用于预先治疗的患者.
相关概念视频
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K